Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Olympus Corporation
  6. News
  7. Summary
    7733   JP3201200007


Delayed Japan Exchange  -  09:30 2022-12-01 pm EST
2685.50 JPY   -3.66%
11/24Japan's leveraged loan market solid despite global turmoil - MUFG exec
11/16Japan's Nikkei ends higher as fears of escalation in Ukraine crisis fade
11/15Japanese shares fall on fears of geopolitical risks
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Olympus globalizes further and invests 32 million euros in new medical equipment repair facilities in Coimbra, Portugal

09/29/2022 | 09:41am EST

Hamburg/Coimbra - After a four-year construction period, Olympus has officially inaugurated its new repair services facilities in Coimbra, Portugal. The facility will be Olympus' highest volume repair center in Europe. Olympus is investing 32 million euros and will create 300 jobs in Coimbra. The state-of-the-art building meets the highest industrial standards with regard to improved services and lead times for Olympus customers, attractive work conditions and use of renewable energy sources. For Olympus, the opening of this new strategic location is yet another important milestone in becoming a leading global medtech company.

Today, during an official inauguration ceremony, the new Olympus European repair facility was opened in the presence of Portugal's Secretary of Economics, the Mayor of Coimbra, the Japanese Ambassador in Portugal as well as other politicians, partners and customers. Among the 300 invited guests, 200 Olympus employees took part in the event.

Constantin Zangemeister, Executive Managing Director for the EMEA region, said in his speech after unveiling the plaque during the event:

'We are very grateful and proud to inaugurate this brand-new facility today and integrate it into our growing European and global Olympus network. To build this new facility in the midst of a pandemic without significant delay has only been possible thanks to the huge efforts of our colleagues in both our EMEA headquarters in Hamburg and here in Coimbra, and our people's close collaboration with and support from all global entities and project partners, suppliers, and our customers.' He highlighted the site's strategic importance: 'Olympus' 32 million euros investment in this larger, more flexible, and modernized repair facility reflects the increasing demand for repair services that come with the global growth of our company's medtech business. With this move, Olympus has passed the next milestone in becoming a globally active, digital, and sustainability-oriented medical technology company. Continuing our journey, Coimbra will certainly serve as an example for future projects.'

From Coimbra to Europe

The new Olympus Medical Products Portugal (OMPP) headquarters is a modern industrial building with a total floor area of 15,500 m-2 dedicated to the repair service of medical devices from throughout Europe. The facility sets innovative standards to implement more efficient processes and technical solutions, continuously ensuring a higher level of quality in repairs as well as shorter turnaround times. Olympus customers benefit from faster service, lower costs, and a more efficient use of resources. The opening of the new facility marks a significant step in the growth strategy of the company globally, expanding its repair business footprint across the whole product lifecycle and providing higher quality services from a single source across the entire EMEA region. Already today, Olympus is providing products and solutions for the top four incidences of cancers, significantly contributing to Our Purpose of making people's lives healthier, safer, and more fulfilling.

Currently, the Coimbra facility is processing about 15,000 items each year. By further centralizing its repair center network and in view of continued market growth, Olympus expects to repair up to 30,000 items annually at its peak.

A long-term, sustainable commitment

The premise of sustainability was a clear priority in the planning and construction of the site. In line with the company's established environmental and social objectives, the construction of the new facility was based on the highest environmental and social standards in order to ensure the sustainable operation of the activity. Consequently, Olympus will make use of solar energy from the rooftop of the building and hence be able to directly power the unit from renewable resources.

Besides the investment in solar panels, a pioneering project in Portugal involving a wastewater treatment system was developed, which will allow the reuse of the treated water for the purpose of irrigating the garden areas, thereby avoiding wastage of drinking water and reducing the environmental impact. All measures contribute to Olympus' global target of achieving CO2 neutrality at all site operations until 2030.

Attractive workplaces across Europe

Olympus currently has 210 employees in Portugal, 40 of which have joined since June 2022. Until the end of 2024, the company intends to employ more than 300 people at the new site. The location, in the heart of Portugal, is strategic: It is an important center for medical research and services in the healthcare sector, with a diversified offer of higher education institutes including the University of Coimbra to help recruit talent in various areas.

The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.

Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.

Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.

All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. and TM marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.


Shinjuku Monolith

2-3-1 Nishi-Shinjuku


Tokyo 163-0914, Japan

Management headquarters

T: (81) 3-3340-2111

(C) 2022 Electronic News Publishing, source ENP Newswire

11/24Japan's leveraged loan market solid despite global turmoil - MUFG exec
11/16Japan's Nikkei ends higher as fears of escalation in Ukraine crisis fade
11/15Japanese shares fall on fears of geopolitical risks
11/14Japan's Olympus says moving from asset sales towards doing deals
11/14Japan Index Descends to Loss on Tech Sellout; SoftBank Shares Crash 13%
11/14Japan's Nikkei slides from 2-month highs; SoftBank drags
11/14Olympus Logs 7% Jump in Fiscal H1 Attributable Profit on Record-high Operating Profit; ..
11/13Japan's Nikkei falls from 2-month high as SoftBank tumbles
11/11Global markets live: SoftBank, Toshiba, Cisco, Apple, AstraZeneca...
11/11Transcript : Olympus Corporation, Q2 2023 Earnings Call, Nov 11, 2022
More news
Analyst Recommendations on OLYMPUS CORPORATION
More recommendations
Sales 2023 933 B 6 693 M 6 693 M
Net income 2023 353 B 2 530 M 2 530 M
Net cash 2023 70 928 M 509 M 509 M
P/E ratio 2023 10,4x
Yield 2023 0,60%
Capitalization 3 572 B 25 636 M 25 636 M
EV / Sales 2023 3,75x
EV / Sales 2024 3,41x
Nbr of Employees 31 557
Free-Float 94,6%
Duration : Period :
Olympus Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OLYMPUS CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 13
Last Close Price 2 806,00 JPY
Average target price 3 727,50 JPY
Spread / Average Target 32,8%
EPS Revisions
Managers and Directors
Yasuo Takeuchi Executive Officer
Chikashi Takeda Chief Financial Officer
Katsuyuki Saito Executive Officer, Head-Corporate R&D
Akira Hasegawa Executive Officer, Head-Research & Development
AndrÚ Roggan Executive Officer & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)